Results 81 to 90 of about 11,874 (206)
Recent work from [Pandithage et al.][1] reveals a new pathway for controlling cell movement that involves a cancer enabler and a member of a protein family best known for boosting longevity. The researchers chanced on the discovery while investigating the oncogene Myc, which is overactive in ...
openaire +2 more sources
Epigenetic control of cellular plasticity in breast cancer progression
Cancer cells undergo cell state transitions, termed plasticity, driving cancer progression and dictating therapeutic response. We define breast cancer plasticity into four interconnected processes: (1) breast cancer stem cell fates, (2) epithelial‐to‐mesenchymal transition, (3) maintenance of luminal identity, and (4) acquisition of therapeutic ...
Ellie J. Massey +2 more
wiley +1 more source
A Novel Transgenic Mouse Model Implicates Sirt2 as a Promoter of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer deaths globally. Incidence rates are steadily increasing, creating an unmet need for new therapeutic options.
Alexandra V. Schmidt +3 more
core +1 more source
ABSTRACT Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most common chronic liver disorder worldwide, affecting approximately one‐third of the population and increasing the risk of severe hepatic and cardiovascular complications.
Shurui Yang +4 more
wiley +1 more source
Abstract figure legend THC and extract administered to diet‐induced obese mice reduced body weight and fat storage. Extract, but not THC, improved glucose clearance by a mechanism that may include restoring adipoinsular function. Abstract Diet‐induced obesity (DIO) is associated with dysregulated adipoinsular axis and endocannabinoid system (eCBS ...
Bryant Avalos +7 more
wiley +1 more source
Mutational analysis of SIRT2 NES sequence.
(A) HeLa cells were transfected with GFP-SIRT2 wild-type or single and double point mutants of the proposed NES sequence. (B) Subcellular distribution results of all single and double mutants of SIRT2 NES analyzed in (A).
Brian J. North (78353) +1 more
core +1 more source
ABSTRACT Atherosclerosis is driven by coordinated changes in endothelial cells (ECs), macrophages, and vascular smooth muscle cells (VSMCs). Post‐translational modifications (PTMs), phosphorylation, acetylation, ubiquitination, SUMOylation, O‐GlcNAcylation, palmitoylation, ISGylation, and ADP‐ribosylation, integrate metabolic, inflammatory, and ...
Weiwei Jiang, Haiping Du
wiley +1 more source
Colocalization of SIRT2 with the centrosome.
(A) U2OS cells expressing SIRT2-HA were stained for HA (green) and for γ-tubulin (red) and analyzed by confocal microscopy. (B) HeLa cells were stained with antisera for endogenous SIRT2 (green) and Aurora A (red) and analyzed by confocal microscopy. (C)
Brian J. North (78353) +1 more
core +1 more source
Additional File 2 Potential targets of deferential expressed genes with fold change > 10 and FDR
Xin Zhao (71840) +4 more
core +1 more source
HaloTag-Targeted Sirtuin Rearranging Ligand (SirReal) for the Development of Proteolysis Targeting Chimeras (PROTACs) Against the Lysine Deacetylase Sirtuin 2 (Sirt2) [PDF]
We have discovered the sirtuin rearranging ligands (SirReals) as a novel class of highly potent and selective inhibitors of the NAD+-dependent lysine deacetylase sirtuin 2 (Sirt2).
Sándor, Szunyogh +10 more
core +2 more sources

